ADMA Biologics (ADMA) Reports Q4 Loss of $0.58
Tweet
Share
E-mailGet Alerts ADMA Hot Sheet
Join SI Premium – FREE
ADMA Biologics (NASDAQ: ADMA) reported Q4 EPS of ($0.58), versus $0.50 reported last year. Revenue for the quarter came in at $524 thousand, versus $30 million reported last year.
For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- General Mills (GIS) Tops Q1 EPS by 3c
- KB Home (KBH) Tops Q3 EPS by 16c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
